ACTINIUM PHARMACEUTICALS, INC. Current Liabilities
ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Current Liabilities of $9.26 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-07
- 2026-06-30: Liabilities, Current $9.26M.
- 2026-03-31: Liabilities, Current $7.35M.
- 2025-12-31: Liabilities, Current $7.97M.
- 2025-09-30: Liabilities, Current $6.83M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $9.26M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $7.35M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $7.97M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $6.83M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $8.31M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $7.11M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $8.15M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $7.75M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $9.73M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $8.06M 10-Q · filed 2024-04-26 | |
| 2023-12-31 | $8.49M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $8.67M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $9.15M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $7.86M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $10.63M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $8.35M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $6.28M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $5.72M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $6.84M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $4.19M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $3.87M 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $4.16M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $4.77M 10-K · filed 2022-03-25 | |
| 2020-09-30 | $4.68M 10-Q · filed 2020-10-23 | |
| 2020-06-30 | $4.66M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $4.71M 10-Q · filed 2020-06-29 | |
| 2019-12-31 | $5.34M 10-K · filed 2021-03-31 | $5.34M 10-K · filed 2020-05-08 |
| 2019-09-30 | $5.54M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $5.18M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $5.85M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $6.06M 10-K · filed 2020-05-08 | |
| 2018-09-30 | $4.12M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $5.27M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $6.39M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $4.67M 10-K · filed 2019-03-15 | |
| 2017-09-30 | $3.53M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $4.11M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $5.37M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $4.52M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $3.03M 10-Q · filed 2016-10-28 | |
| 2016-06-30 | $2.49M 10-Q · filed 2016-07-29 | |
| 2016-03-31 | $3.29M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $4.61M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $2.16M 10-Q · filed 2015-10-30 | |
| 2015-06-30 | $3.05M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $3.61M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $9.49M 10-K · filed 2016-03-11 | |
| 2014-09-30 | $10.23M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $11.12M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $20.03M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $7.33M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $3.45M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $3.82M 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $2.81M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $4.64M 10-K · filed 2014-02-28 | |
| 2012-09-30 | $31.14K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $29.16K 10-Q/A · filed 2012-08-29 | |
| 2012-03-31 | $29.93K 10-Q · filed 2012-04-23 | |
| 2011-12-31 | $5.21M 10-K · filed 2013-03-29 | $26.31K 10-K · filed 2012-04-12 |
| 2011-09-30 | $28.08K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $24.57K 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $36.06K 10-K · filed 2012-04-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |